CTRI/2024/06/068563尚未招募2 期
A Single Blind Randomised Clinical Study on the Efficacy of Two Unani formulations in the management of Huzaz (Dandruff)
Department of Amraz e Jild wa Zohrawiya1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年7月10日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Changes in Adherent Scalp Flaking Score
研究概览
简要总结
AIMS AND OBJECTIVES OF THE STUDY:
To evaluate the safety and efficacy of Hulba (Fenugreek) solution and Chuqandar (Beetroot) solutionin the management of Huzaz.
To compare the effects of Hulba solution and Chuqandar solution in the management of Huzaz
PURPOSE AND BACKGROUND OF THE STUDY:
Dandruff is a chronic disease with relapses and remissions. Hence, for its long-term management, it is imperative to search for medicines that are efficacious and have the least adverse effects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 55.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients of either sex above 18 years of age.
- •Patients with Adherent Scalp Flaking Score (ASFS) up to grade 3 i.e., thick heaped-up scales but not forming plaque.
- •3.Patients who agreed to sign the consent form.
排除标准
- •Patients below 18 years of age.
- •Patients who underwent local procedures within the past 2 weeks or during the study.
- •pregnant or lactating females.
- •Patients with other concomitant skin diseases like psoriasis, Tinea capitis, eczema and atopic dermatitis (as per history and clinical examination).
- •Patients using other topical medications, including medicated shampoos/oils or antibiotics, within past 2 weeks or during course of trial.
- •Patients suffering from severe systemic illness.
结局指标
主要结局
Changes in Adherent Scalp Flaking Score
时间窗: 0, 7th, 14th and 21st day
次要结局
- Improvement in scalp itching and flaking(0,7th, 14th and 21st day)
研究者
Maleeha Zehra
Ajmal Khan Tibbiya College
研究点 (1)
Loading locations...
相似试验
尚未招募
2/3 期
Study The Effect of Bhunimba Churna With Madhu In Garbhini Hrullas (Nausea In Pregnancy)CTRI/2024/05/067224DR Smruti Vijaykumar Honmute40
招募中
2 期
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT07363694Pfizer1,156
尚未招募
2 期
A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICCIntrahepatic CholangiocarcinomaNCT07432568Tianjin Medical University Cancer Institute and Hospital30
招募中
1 期
A Study of CNCT19 in the Treatment of Relapsed or Refractory Neurological Autoimmune DiseasesNCT07275736Juventas Cell Therapy Ltd.18
尚未招募
1 期
A Study of HY001N in the Treatment of Relapsed or Refractory Neurological Autoimmune DiseasesNCT07265206Juventas Cell Therapy Ltd.15